Valuation: AstraZeneca PLC

Capitalization 281B 241B 226B 211B 389B 25,273B 423B 2,645B 1,021B 11,936B 1,054B 1,031B 43,644B P/E ratio 2025 *
27.3x
P/E ratio 2026 * 23.5x
Enterprise value 302B 260B 243B 227B 419B 27,207B 456B 2,847B 1,099B 12,850B 1,135B 1,110B 46,983B EV / Sales 2025 *
5.16x
EV / Sales 2026 * 4.75x
Free-Float
96.62%
Yield 2025 *
1.78%
Yield 2026 * 1.88%
More valuation ratios * Estimated data
Dynamic Chart
1 day+0.58%
1 week-2.73%
Current month-2.73%
1 month+5.36%
3 months+12.42%
6 months+26.06%
Current year+29.84%
More quotes
1 week 13,452
Extreme 13452
13,826
1 month 12,840
Extreme 12840
14,206
Current year 9,573.5
Extreme 9573.505
14,206
1 year 9,573.5
Extreme 9573.505
14,206
3 years 9,461
Extreme 9461
14,206
5 years 6,736
Extreme 6736
14,206
10 years 3,680
Extreme 3680
14,206
More quotes
Manager TitleAgeSince
Chief Executive Officer 65 01/10/2012
Director of Finance/CFO 51 01/08/2021
Chief Tech/Sci/R&D Officer - 01/08/2023
Director TitleAgeSince
Director/Board Member 69 06/04/1999
Director/Board Member 65 01/10/2012
Director/Board Member 64 27/04/2017
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+0.58%-2.73%+27.58%+20.73% 281B
-0.41%-6.06%+22.21%+171.61% 905B
-0.27%-2.41%+35.24%+13.98% 487B
-1.15%-0.71%+28.32%+36.69% 400B
+0.26%+1.14%+20.97%+3.22% 330B
+0.19%+2.49%+19.23%+24.83% 255B
-1.16%-4.87%-3.27%-9.42% 248B
+1.24%-2.33%-60.59%-30.34% 214B
-3.02%-4.51%+21.03%+15.44% 178B
-1.14%-3.67%+31.57%+38.08% 150B
Average -0.49%-2.37%+14.23%+28.48% 344.69B
Weighted average by Cap. -0.40%-2.83%+18.23%+54.99%
See all sector performances

Financials

2025 *2026 *
Net sales 58.54B 50.32B 47.14B 43.94B 81.15B 5,268B 88.27B 551B 213B 2,488B 220B 215B 9,098B 62.28B 53.53B 50.15B 46.74B 86.34B 5,605B 93.91B 587B 226B 2,647B 234B 229B 9,679B
Net income 10.3B 8.86B 8.3B 7.73B 14.28B 927B 15.54B 97.04B 37.47B 438B 38.67B 37.84B 1,601B 12.07B 10.37B 9.72B 9.06B 16.73B 1,086B 18.19B 114B 43.88B 513B 45.29B 44.32B 1,875B
Net Debt 21.48B 18.47B 17.3B 16.12B 29.78B 1,933B 32.39B 202B 78.13B 913B 80.63B 78.91B 3,339B 15.3B 13.16B 12.32B 11.49B 21.22B 1,377B 23.08B 144B 55.66B 651B 57.44B 56.22B 2,379B
More financial data * Estimated data
Logo AstraZeneca PLC
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (94.2%). Net sales break down by treatment area between oncology (39.8%), cardiovascular, renal and metabolic diseases (24.4%), respiratory and autoimmune diseases (14.6%), and other (21.2%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (5.8%). Net sales are distributed geographically as follows: the United Kingdom (8.8%), Europe (21.6%), the United States (40.3%), Americas (5.9%) and Africa/Asia/Australia (23.4%).
Employees
94,300
More about the company
Date Price Change Volume
05/12/25 13,592.00 p +0.58% 1,501,116
04/12/25 13,514.00 p -1.31% 1,868,518
03/12/25 13,694.00 p -0.77% 1,966,627
02/12/25 13,800.00 p -0.26% 1,678,958
01/12/25 13,836.00 p -0.99% 2,063,349

Delayed Quote London S.E., 06 December 2025 at 03:35 am AEDT

More quotes
Trader
Investor
Global
Quality
ESG MSCI
A
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
181.09USD
Average target price
197.15USD
Spread / Average Target
+8.87%
Consensus

Quarterly revenue - Rate of surprise